TMZ is an important chemotherapy agent [16] acclaimed as the gold standard for the treatment of GBM and in a previous report, it was shown that glioma cells considerably became more sensitive to temozolomide treatment after BRCA2 knockdown [17]. This evidence concerns the gene BRCA2 and glioma.